19 June 2013
Keywords: galvus, gets, positive, opinion, chmp, swiss, drug
Article | 24 December 2007
Swiss drug major Novartis has received a positive opinion recommending European Union approval of Galvus (vildagliptin) as a new, once-daily
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 December 2007
17 December 2007
18 June 2013
© 2013 thepharmaletter.com